Literature DB >> 8839998

Transmission of a procoagulant signal from tissue factor-bearing cell to platelets.

D M Monroe1, M Hoffman, H R Roberts.   

Abstract

The goal of the current study was to examine the mechanism by which factor VIIa/tissue factor (TF) activity leads to platelet activation as the first step in initiation of coagulation. Adherent, endotoxin-treated monocytes were used as a cellular source of TF. The processes that led to platelet activation were rapid, since incubation of coagulation factors and platelets with TF for as little as 15 s initiated platelet activation. Further, direct contact between the TF source and platelets was not required since incubation of plasma levels of coagulation zymogens and inhibitors with TF generated the initiating signal for platelet activation. We hypothesized that thrombin generation on the cells that contained TF was the initiating signal for platelet activation. To test this hypothesis, factor VIIa, inhibitors, and different combinations of coagulation zymogens were incubated with TF-bearing cells. The supernatants were then transferred to a suspension of unactivated platelets with plasma concentrations of zymogen factors and inhibitors. Platelet activation was much more efficient when all the elements of the IIase complex (factors II, V and X) were preincubated with factor VIIa/TF than when only factor X was incubated with factor VIIa/TF. Finally, TF was incorporated into lipid vesicles containing phosphatidyl choline either with or without phosphatidyl serine. Vesicles without phosphatidyl serine have no IIase activity. Platelets were incubated with TF, coagulation zymogens and inhibitors. Platelet activation only occurred when the lipid vesicles could support IIase activity. We conclude that sufficient thrombin generation occurs on the TF-bearing cell (or TF-bearing vesicle) in the absence of platelets, to provide the procoagulant signal that leads to platelet activation. The activated platelet surface then provides sites for TF-activated factor IXa to recruit factor Xa to bind and assemble into functional Xase and IIase complexes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839998     DOI: 10.1097/00001721-199606000-00005

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  27 in total

Review 1.  Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis?

Authors:  M Hoffman; D M Monroe; R A Roubey
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis.

Authors:  Robert A Campbell; Adriana Vieira-de-Abreu; Jesse W Rowley; Zechariah G Franks; Bhanu Kanth Manne; Matthew T Rondina; Larry W Kraiss; Jennifer J Majersik; Guy A Zimmerman; Andrew S Weyrich
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-03       Impact factor: 8.311

Review 3.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

4.  Task-oriented modular decomposition of biological networks: trigger mechanism in blood coagulation.

Authors:  Mikhail A Panteleev; Anna N Balandina; Elena N Lipets; Mikhail V Ovanesov; Fazoil I Ataullakhanov
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 5.  Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.

Authors:  Thomas J Povsic; Bruce A Sullenger; Steven L Zelenkofske; Christopher P Rusconi; Richard C Becker
Journal:  J Cardiovasc Transl Res       Date:  2010-11-16       Impact factor: 4.132

6.  Positive feedback loops for factor V and factor VII activation supply sensitivity to local surface tissue factor density during blood coagulation.

Authors:  A N Balandina; A M Shibeko; D A Kireev; A A Novikova; I I Shmirev; M A Panteleev; F I Ataullakhanov
Journal:  Biophys J       Date:  2011-10-19       Impact factor: 4.033

Review 7.  The role of oral anticoagulant therapy in patients with acute coronary syndrome.

Authors:  Jae Youn Moon; Deepa Nagaraju; Francesco Franchi; Fabiana Rollini; Dominick J Angiolillo
Journal:  Ther Adv Hematol       Date:  2017-10-13

Review 8.  Oral factor Xa inhibitors for the long-term management of ACS.

Authors:  James W Wisler; Richard C Becker
Journal:  Nat Rev Cardiol       Date:  2012-02-21       Impact factor: 32.419

Review 9.  Thrombin generation, fibrin clot formation and hemostasis.

Authors:  Alisa S Wolberg; Robert A Campbell
Journal:  Transfus Apher Sci       Date:  2008-02-20       Impact factor: 1.764

10.  Thrombin activity propagates in space during blood coagulation as an excitation wave.

Authors:  N M Dashkevich; M V Ovanesov; A N Balandina; S S Karamzin; P I Shestakov; N P Soshitova; A A Tokarev; M A Panteleev; F I Ataullakhanov
Journal:  Biophys J       Date:  2012-11-20       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.